openPR Logo
Press release

Investigation announced for Long Term Investors in shares of J2 Global, Inc. (NASDAQ: JCOM)

10-23-2020 11:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in J2 Global, Inc. (NASDAQ: JCOM) shares.

An investigation on behalf of current long term investors in J2 Global, Inc. (NASDAQ: JCOM) shares.

An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of J2 Global, Inc..

Investors who are current long term investors in J2 Global, Inc. (NASDAQ: JCOM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: JCOM stocks follows a lawsuit filed against J2 Global, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: JCOM stocks, concerns whether certain J2 Global directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that J2 Global engaged in undisclosed related party transactions, that J2 Global used misleading accounting to hide requisite impairments and underperformance in acquisitions, that several so-called independent members of the Company’ board of directors and audit committee were not disinterested, and that as a result, defendants’ public statements were materially false and/or misleading at all relevant times.

Those who purchased shares of J2 Global, Inc. (NASDAQ: JCOM) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long Term Investors in shares of J2 Global, Inc. (NASDAQ: JCOM) here

News-ID: 2170544 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors who lost money with shares of Altimmune, Inc. (NASDAQ: ALT) over possible Violations of Securities Laws
Investigation announced for Investors who lost money with shares of Altimmune, I …
An investigation was announced for investors of Altimmune, Inc. (NASDAQ: ALT) shares over potential securities laws violations by Altimmune, Inc. Investors who purchased shares of Altimmune, Inc. (NASDAQ: ALT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Altimmune, Inc. (NASDAQ: ALT) concerning whether a series
Investigation announced for Long-Term Investors in shares of Medical Properties Trust, Inc. (NYSE: MPW) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of Medical Properties …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Medical Properties Trust, Inc.. Investors who are current long term investors in Medical Properties Trust, Inc. (NYSE: MPW) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: MPW stocks follows a lawsuit filed
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced for investors of Designer Brands Inc. (NYSE: DBI) shares over potential securities laws violations by Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Designer Brands Inc. (NYSE: DBI)
Investigation announced for Investors in shares of Pyxis Oncology, Inc. (NASDAQ: PYXS) over potential Wrongdoing
Investigation announced for Investors in shares of Pyxis Oncology, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Pyxis Oncology, Inc. Investors who purchased shares of Pyxis Oncology, Inc. (NASDAQ: PYXS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Pyxis Oncology, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Cambridge,

All 5 Releases


More Releases for NASDAQ:

Zillow Group, Inc. (NASDAQ: Z, NASDAQ: ZG) Investor Notice: Update in Lawsuit ag …
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in Zillow Group, Inc. (NASDAQ: Z, NASDAQ: ZG). Investors who purchased shares of Zillow Group, Inc. (NASDAQ: Z, NASDAQ: ZG) and currently hold any of those NASDAQ: MTCH shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On November 16, 2021, a lawsuit was filed against Zillow Group,
Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) Investor Alert: Deadline in Lawsu …
A deadline is coming up on March 8, 2022in the lawsuit filed for certain investors of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) over alleged securities laws violations by Goldman Sachs and Morgan Stanley Investors who purchased shares of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) have certain options and there are strict and short deadlines running. Deadline: March 8, 2022. Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) stockholders should contact the Shareholders Foundation
Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) Investor Notice: Lawsuit alleges …
An investor, who purchased shares of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws. Investors who purchased a significant amount of shares of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) between March 22, 2021 and March 29, 2021, have certain options and for certain investors are short and strict deadlines running. Deadline:
Investigation for NASDAQ: FREQ Investors over possible Wrongdoing at Frequency T …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Frequency Therapeutics, Inc. Investors who purchased shares of Frequency Therapeutics, Inc. (NASDAQ: FREQ) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Frequency Therapeutics, Inc. (directors breached their fiduciary duties and caused damage to the company and its shareholders. Woburn,
Investigation announced for Investors in shares of Alphabet Inc. (NASDAQ: GOOG, …
An investigation was announced on behalf of investors of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL) shares over potential securities laws violations by Alphabet Inc. in connection with certain financial statements. Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers
Oncolytic Virus Therapy Market 2020 Research and Clinical Analysis - Amgen(NASDA …
"Global Oncolytic Virus Therapy Market Report 2020-2026" helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market - driven results deriving feasibility studies for client needs. Marketinsightsreports ensures qualified and verifiable aspects of market data operating in the real- time scenario. The analytical studies are conducted ensuring client needs with a thorough understanding of market capacities in